Virginia Doctors Use Steam to Treat Prostate Cancer

For men facing prostate cancer, the cure has often felt as daunting as the disease itself. Up to 70% of patients who undergo traditional surgery experience erectile dysfunction, and many struggle with urinary problems that can last a lifetime.

Now doctors in Virginia Beach are offering new hope. On Monday, oncologist Robert Given performed the first water vapor ablation for prostate cancer outside of clinical trials on the East Coast, using heated steam to destroy tumors while leaving surrounding tissue untouched.

The treatment works by delivering steam through the urethra to target specific areas where cancer has been detected. Unlike surgery or radiation that treats the entire prostate, this approach focuses only on the tumor itself.

The difference in side effects is striking. In a two-year clinical trial involving over 200 patients nationwide, fewer than 10% experienced erectile dysfunction. Urinary incontinence was minimal, a stark contrast to the 50% to 70% who face these problems after traditional surgery.

Given, who works at Urology of Virginia and teaches at Eastern Virginia Medical School, sees this as a game changer for early detection. When cancer is caught early and confined to one area, patients can now receive treatment without sacrificing their quality of life.

The technique isn't suitable for everyone. Given estimates fewer than 25% of prostate cancer patients will qualify as candidates. The cancer must be localized and caught early to work effectively.

About 15 patients at Urology of Virginia participated in the clinical trials. While some needed repeat treatments due to residual cancer, complication rates remained remarkably low compared to standard approaches.

The Bright Side

This breakthrough joins a growing movement in cancer care called focal therapy, which treats only the diseased portion of an organ rather than removing or irradiating the whole thing. The philosophy represents a fundamental shift from the aggressive "treat everything" approach that has dominated medicine for decades.

The technology itself builds on methods already proven safe. Similar water vapor treatments have been used successfully for years to treat benign prostate enlargement, giving doctors confidence in the safety profile.

Given emphasizes this isn't meant to replace existing treatments but to give patients more options. For men whose cancer is caught early, it could mean the difference between living with debilitating side effects or maintaining the life they had before diagnosis.

The procedure also addresses a major concern in prostate cancer care: overtreatment. Many slow-growing prostate cancers might never cause serious harm, yet traditional treatments carry guaranteed risks. This targeted approach offers a middle ground for patients and doctors navigating difficult decisions.

As word spreads about the availability of this treatment outside clinical trials, more men facing early-stage prostate cancer now have a reason for optimism about life after treatment.